Sintx Technologies (SINT) Gains from Investment Securities (2013 - 2014)
Sintx Technologies (SINT) posted quarterly Gains from Investment Securities of $114000.0 for Q1 2014, down 64.26% year-over-year from $319000.0 in Q1 2013, and down 64.26% quarter-over-quarter from $319000.0 in Q1 2013.
Sintx Technologies (SINT) Gains from Investment Securities (2013 - 2014) Analysis & Trends
Sintx Technologies' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $114000.0 for Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Sintx Technologies | 7.53 Mn | 7.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2014 | 114,000.00 |
| Mar 31, 2014 | 114,000.00 |
| Mar 31, 2013 | 319,000.00 |
| Mar 31, 2013 | 319,000.00 |